gallic acid has been researched along with Invasiveness, Neoplasm in 17 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study investigated the chemotherapy activity and molecular targets of Ethyl gallate, which is identified as the major constituent extracted from the roots of Euphorbia fischeriana Steud in breast cancer cell lines in vitro." | 7.81 | Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling. ( Cui, H; Du, X; Liu, J; Wang, M; Yuan, J; Yue, L, 2015) |
| "Gallic acid (GA) can inhibit the growth of human cancer cells in vitro and in vivo." | 5.37 | Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. ( Chen, HY; Chung, JG; Lai, TY; Lin, HY; Lin, JG; Lo, C; Ma, YS; Weng, SW; Yang, JH; Yang, JS, 2011) |
| " The present study investigated the chemotherapy activity and molecular targets of Ethyl gallate, which is identified as the major constituent extracted from the roots of Euphorbia fischeriana Steud in breast cancer cell lines in vitro." | 3.81 | Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling. ( Cui, H; Du, X; Liu, J; Wang, M; Yuan, J; Yue, L, 2015) |
| " The hypothesis is that blocking FASN, in combination with anti-HER2 signaling agents, would be an effective antitumor strategy in preclinical HER2+ breast cancer models of trastuzumab and lapatinib resistance." | 3.81 | Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs. ( Blancafort, A; Brugada, R; Campuzano, Ò; Carrión-Salip, D; Giró-Perafita, A; Gómez-Miragaya, J; González-Suárez, E; Massaguer, A; Oliveras, G; Palafox, M; Palomeras, S; Puig, T; Turrado, C, 2015) |
| "Gallic acid (GA) is a polyhydroxy phenolic compound which can inhibit the growth of cancer cells." | 1.43 | The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells. ( Ghatreh-Samani, K; Heidarian, E; Keloushadi, M; Valipour, P, 2016) |
| "Gallic acid (GA) is a natural product that induces cell death through cell cycle arrest and induction of apoptosis." | 1.40 | Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9. ( Chung, JG; Kuo, CL; Lai, KC; Lin, JP; Ma, YS; Weng, SW, 2014) |
| "Gallic acid (GA) has been demonstrated to possess multiple biological activities including anticancer function." | 1.37 | Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. ( Chiang, JH; Chueh, FS; Chung, JG; Huang, AC; Lin, HY; Liu, KC; Lu, CC; Meng, M; Wu, PP; Yang, JS, 2011) |
| "Gallic acid (GA) can inhibit the growth of human cancer cells in vitro and in vivo." | 1.37 | Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. ( Chen, HY; Chung, JG; Lai, TY; Lin, HY; Lin, JG; Lo, C; Ma, YS; Weng, SW; Yang, JH; Yang, JS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Velu, P | 1 |
| Vijayalakshmi, A | 1 |
| Vinothkumar, V | 1 |
| Wu, CW | 1 |
| Wang, SG | 1 |
| Lee, CH | 1 |
| Chan, WL | 1 |
| Lin, ML | 1 |
| Chen, SS | 1 |
| Naves, MA | 1 |
| Graminha, AE | 1 |
| Vegas, LC | 1 |
| Luna-Dulcey, L | 1 |
| Honorato, J | 1 |
| Menezes, ACS | 1 |
| Batista, AA | 1 |
| Cominetti, MR | 1 |
| Kuo, CL | 1 |
| Lai, KC | 2 |
| Ma, YS | 2 |
| Weng, SW | 2 |
| Lin, JP | 1 |
| Chung, JG | 4 |
| Kim, SR | 1 |
| Eom, TK | 1 |
| Byun, HG | 1 |
| Cui, H | 1 |
| Yuan, J | 1 |
| Du, X | 1 |
| Wang, M | 1 |
| Yue, L | 1 |
| Liu, J | 2 |
| Blancafort, A | 1 |
| Giró-Perafita, A | 1 |
| Oliveras, G | 1 |
| Palomeras, S | 1 |
| Turrado, C | 1 |
| Campuzano, Ò | 1 |
| Carrión-Salip, D | 1 |
| Massaguer, A | 1 |
| Brugada, R | 1 |
| Palafox, M | 1 |
| Gómez-Miragaya, J | 1 |
| González-Suárez, E | 1 |
| Puig, T | 1 |
| Guimaraes, TA | 1 |
| Farias, LC | 1 |
| Fraga, CA | 1 |
| Feltenberger, JD | 1 |
| Melo, GA | 1 |
| Coletta, RD | 1 |
| Souza Santos, SH | 1 |
| de Paula, AM | 1 |
| Guimaraes, AL | 1 |
| Park, J | 1 |
| Shim, MK | 1 |
| Jin, M | 1 |
| Rhyu, MR | 1 |
| Lee, Y | 1 |
| Zhou, Y | 1 |
| Xu, M | 1 |
| Liu, Y | 1 |
| Bai, Y | 1 |
| Deng, Y | 1 |
| Chen, L | 1 |
| Heidarian, E | 1 |
| Keloushadi, M | 1 |
| Ghatreh-Samani, K | 1 |
| Valipour, P | 1 |
| Liu, KC | 1 |
| Huang, AC | 2 |
| Wu, PP | 1 |
| Lin, HY | 2 |
| Chueh, FS | 1 |
| Yang, JS | 3 |
| Lu, CC | 1 |
| Chiang, JH | 1 |
| Meng, M | 1 |
| Lo, C | 1 |
| Lai, TY | 1 |
| Yang, JH | 1 |
| Chen, HY | 1 |
| Lin, JG | 2 |
| Liao, CL | 1 |
| Lin, JJ | 1 |
| Wu, SH | 1 |
| Gibson Wood, W | 1 |
| Ho, HH | 1 |
| Chang, CS | 1 |
| Ho, WC | 1 |
| Liao, SY | 1 |
| Lin, WL | 1 |
| Wang, CJ | 1 |
| Saeki, K | 2 |
| Shoji, Y | 2 |
| Noro, T | 1 |
| Miyase, T | 1 |
| Nakamura, Y | 1 |
| Funayama, M | 1 |
| Isemura, M | 2 |
| Minami, T | 1 |
| Hayakawa, S | 1 |
| Kimura, T | 1 |
| Sazuka, M | 1 |
17 other studies available for gallic acid and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Adhesion; | 2020 |
Enforced C-Src Activation Causes Compartmental Dysregulation of PI3K and PTEN Molecules in Lipid Rafts of Tongue Squamous Carcinoma Cells by Attenuating Rac1-Akt-GLUT-1-Mediated Sphingolipid Synthesis.
Topics: Carcinoma, Squamous Cell; Cell Compartmentation; Cell Line, Tumor; Down-Regulation; Enzyme Activatio | 2020 |
Transport of the Ruthenium Complex [Ru(GA)(dppe)
Topics: Antineoplastic Agents; Apoptosis; Biological Transport, Active; Cell Line, Tumor; Cell Movement; Cis | 2019 |
Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9.
Topics: Cell Line, Tumor; Cell Movement; Cell Survival; Gallic Acid; Humans; Matrix Metalloproteinase 2; Mat | 2014 |
Inhibitory effect of the carnosine-gallic acid synthetic peptide on MMP-2 and MMP-9 in human fibrosarcoma HT1080 cells.
Topics: Antineoplastic Agents; Carnosine; Cell Line, Tumor; Cell Movement; Fibrosarcoma; Gallic Acid; Humans | 2014 |
Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling.
Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proli | 2015 |
Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Catechin; Cell | 2015 |
Evaluation of the antineoplastic activity of gallic acid in oral squamous cell carcinoma under hypoxic conditions.
Topics: Antineoplastic Agents; Cadherins; Carcinoma, Squamous Cell; Caspase 3; Cell Hypoxia; Cell Line, Tumo | 2016 |
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells.
Topics: Calcium Channels; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Epithelial Cells; | 2016 |
Green synthesis of Se/Ru alloy nanoparticles using gallic acid and evaluation of theiranti-invasive effects in HeLa cells.
Topics: Alloys; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Gallic Acid; Green Chem | 2016 |
The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Resp | 2016 |
Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Gallic Acid; Gene | 2011 |
Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Ce | 2011 |
Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways.
Topics: Base Sequence; Blotting, Western; Cell Line, Tumor; Cell Movement; DNA Primers; Gallic Acid; Humans; | 2012 |
Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity.
Topics: Animals; Cell Line, Tumor; Down-Regulation; Gallic Acid; Gene Expression Regulation, Neoplastic; GTP | 2013 |
Inhibitory effects of tetragalloylglucose and digalloylhamamelose on adhesion and in vitro invasion of mouse lung carcinoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Division; Gallic Acid; Gluco | 1999 |
Inhibition of matrix metalloproteinases by tea catechins and related polyphenols.
Topics: Biflavonoids; Catechin; Cell Line; Fibrosarcoma; Flavonoids; Gallic Acid; Gene Expression Regulation | 1999 |